Amaç: Bu prospektif olgu-kontrollü çal›flmada Sinonazal Sonuç Testinin (SNOT-22) Türkçeye çevirisi, kültürler aras› adaptasyonu ve validasyonunu gerçeklefltirmeyi amaçlad›k.
Chronic rhinosinusitis (CRS) is a disease covering all inflammatory processes affecting the nose and paranasal sinus, producing symptoms lasting over 12 weeks. [1, 2] The most common symptoms are nasal congestion or obstruction, hyposmia or anosmia, facial pain, anterior or posterior nasal secretion and nasal pressure. [3] [4] [5] Overall prevalence of CRS in Europe and US were reported to be 10.9 and 15%, respectively. [6] [7] [8] CRS is often treated symptomatically and with repeated surgery, leading to lifelong systemic steroid treatment and impaired olfaction. [2, 5, 9] It causes a significant reduction in the quality of life through physical pain and social performance compared to angina, congestive heart failure, back pain and chronic obstructive pulmonary disease. [2, [10] [11] [12] Numerous instruments have been developed in recent years to measure the health status or quality of life in patients with CRS. Health status can be described by physicians or other healthcare professionals based on physical limitations, functional handicaps or social experiences; however, quality of life depends on personal experience and, therefore, is unique and should be described by the patient him or herself. SinoNasal Outcome Test (SNOT-22), modified form of SNOT-20, is a broadly used, validated, patient-reported, disease-specific questionnaire for the assessment of quality of life in patients with nasosinusal diseases. [2, 5, [10] [11] [12] [13] [14] The questionnaire contains 22 items graded in 6 levels (0 for no problem, 5 for worst possible symptom) and the final score is obtained by adding scores for items (range: 0 to 110, from best to worst quality of life). [15] SNOT-22 questionnaire has a specific advantage of evaluating the impact of sinonasal disease on both specific and general health issues before and after the operation. [2, 11, 16] SNOT-22 questionnaire is in English and has been translated and validated in several languages including Brazilian Portuguese, [11, 12] Czech, [10] Danish, [2] French, [5] Greek, [4, 17] Lithuanian, [8] Persian, [15] and Spanish. [18] Even though SNOT-22 questionnaire is recommended for its use in CRS, it is not yet available in Turkish. By taking account that, an effective translation of SNOT-22 into other languages should consider cultural and linguistic differences; in this study, we aimed to translate, culturally adapt and validate the SNOT-22 questionnaire from English into Turkish.
Materials and Methods
This study was carried out in two main stages; translation of SNOT-22 to Turkish, and a prospective study with patients diagnosed with CRS at the Otolaryngology Clinic of Yunus Emre Hospital between January and March 2015 to inves- 
Inclusion-exclusion criteria
Only adult patients with CRS (with/without nasal polyps) diagnosed according to EPOS criteria [19] were included in this prospective study. The exclusion criteria were age below 18 years and pregnancy. In cases where SNOT-22 items were incomplete but more than 50% of the test items had been answered, the total score was calculated as the mean of completed items. [14] Test-retest study
The test-retest reliability was carried out in patients with CRS. SNOT-22 questionnaire was applied twice by two different physicians during routine visits of the patient. CRS patients with change in treatment, and acute change of symptoms due to common cold, influenza or respiratory tract infection during two visits were excluded from the study.
Control study
Members of the medical staff, hospital staff, and accompanying persons/relatives of our patients were recruited as a control group. Respondents with a history of CRS with/without polyps or any other nasal problem and/or using nasal medication during the study were excluded. Subjects were first examined with nasal endoscopy and SNOT-22 scores were then obtained.
Preoperative-postoperative evaluation
The surgery subgroup consisted of study group patients who underwent surgical treatment. These patients were evaluated once the day before surgery and again 3 months postoperatively with the SNOT-22 questionnaire translated into Turkish.
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Statistical analysis
Statistical analysis was performed by the SPSS software package for Windows (Statistical Package for Social Sciences, version 12.0, SPSS Inc., Chicago, IL, USA). Categorical variables were given as numbers and percentages and quantitative variables as mean±standard deviation (SD), median, minimum and maximum values. The level of significance was set at p<0.05 for all analyses.
Internal consistency of Turkish version of SNOT-22, referring the way in which the items relate to each other, was analyzed with Cronbach's alpha with a minimum acceptable value of 0.7. The Cronbach's alpha coefficient was calculated for all items at first and then by removing each item at once. Test-retest reliability, reflecting stability over time with repeated testing, was analyzed by correlating initial test and subsequent test scores with Pearson's 
Sino-Nasal Outcome Test (SNOT-22) (Sinüs-Burun Sonuç Testi)
Hasta ad›, soyad›: Tarih: Ameliyat: Kontrol:
Afla¤›da rinosinüzitinizin semptom ve sosyal/duygusal etkileriyle ile ilgili bir liste bulacaks›n›z. Bu problemleriniz hakk›nda daha çok bilgi sahibi olmak istiyoruz ve bu sorulara en uygun flekilde cevap verirseniz memnun olaca¤›z. Do¤ru veya yanl›fl cevap yoktur. Geçmifl 2 haftadaki yaflad›¤›n›z problemlerinizi derecelendiriniz. Kat›l›m›n›z için teflekkür ederiz. Aç›klama gerekti¤i zaman yard›m istemekten çekinmeyiniz. 
Results
In this study, we tested three different groups for the validation of SNOT-22 translated into Turkish. Results of all studies summarizing group subjects' mean SNOT-22 scores are given in Table 1 . Table 2 .
Test-retest study
Control study
The control group included 104 volunteers from medical staff, hospital staff, and accompanying persons/relatives of our patients. 
Discussion
The use of quality of life questionnaire in daily clinical practice plays a significant role in understanding patients' disease and treatment outcomes. The SNOT-22 questionnaire is an extensively tested, validated in several languages, widely used both in research and in clinical practice and the instrument of choice for evaluation of quality of life of patients with CRS. [2] [3] [4] [5] 8, [10] [11] [12] 15, 17, 18, 20] The questionnaire has advantages both for the patient (quick and easy to complete and understand) and the researcher (rational and easy to apply). In addition, the SNOT-22 score highly depend on personal experience; therefore, a better understanding of each patient's unique condition with regard to his/her symptoms and his/her expectations from treatment outcomes can uniquely be evaluated. In this study, we aimed to translate, cross-culturally adapt, and validate the SNOT-22 questionnaire to Turkish, since there is no standardized questionnaire available in Turkish to measure the quality of life of CRS patients.
The translation, cross-cultural adaptation, and validation of the Turkish version of the SNOT-22 questionnaire were carried out following the generally accepted methodology as described by Koller et al. [21] An excellent reliability score (0.97) and a good internal consistency
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Hanc› D et al. score (Cronbach's alpha=0.89 in the initial test, and 0.93 in the retest) were obtained. Internal consistency score refers to the relation of items within an instrument and the minimum acceptable value for Cronbach's alpha test is considered to be 0.7, above 0.8 as good and more than 0.9 as excellent. [4, 8, 14, 18] Test-retest reliability represents the stability of instrument items over time with repeated testing, and when compared to other cross-cultural adaptation and validation studies summarized in Table 3 , the SNOT-22 questionnaire in Turkish reached the highest reliability score suggesting a very strong correlation between the scores of the initial test and the retest examination (Pearson's correlation coefficient R=0.97). This observation might be related with the gender distribution, which was shown to affect the SNOT-22 scores. [22] In all the groups involved in this study (test-retest, control and preoperative-postoperative groups) percentages of men or women individuals were almost equal, whereas in other studies the population were either men or women dominant. [2, 4, 5] Finally, reproducibility of the SNOT-22 in Turkish was evaluated with kappa test. Lange et al. [2] reported a mean kappa value of 0.61, Lachanas et al. [4] 0.65 and de los Santos et al. [18] 0.61, and here in this study the mean kappa value of each item was 0.83, which indicated a substantial agreement and a high-level of reproducibility of the SNOT-22 questionnaire in Turkish (Table 3 ).
The patients with sinonasal diseases and individuals without nasal disease can be differentiated with the SNOT-22 questionnaire. [8] We tested the ability of SNOT-22 questionnaire in Turkish for its capacity to reflect the differences between known groups by evaluating the mean SNOT-22 scores of 42 patients and those of 104 healthy subjects. The comparison of the mean values of the scores of patients with CRS (57.98±5.07) with those of healthy individuals (15.58±1.41) indicated statistically significant difference between the two groups (p<0.001, Table 1 ). Gillett et al. [23] in their study evaluated the median score of 7 as the "normal" SNOT-22 score in a group of 116 healthy individuals. In this study, we evaluated the median score of patients with CRS as 58, and that of healthy individuals used as a control group as 15, over the value indicated by Gillett et al. [23] This bias might be related with the choice of control group, as in the other studies, no relevant physical examination was carried out in this group; therefore, participants might have, but unaware of the presence of mild sinonasal conditions. Another explanation could be related with the difference between the demographic characteristics of the control group used in our study and the study reported by Gillett et al. [23] In their study, Gillett et al. [23] recruited hospital members and members of a tennis club to evaluate the mean SNOT-22 score of normal population and pointed out that the presence of individuals having a sportive life might have affected the outcomes and a larger study still needs to be performed to validate the results they have reported.
Finally, SNOT-22 is an effective tool to evaluate the effect of medical or surgical treatment on the quality of life of patients with CRS. [24, 25] The responsiveness of the Turkish version of the SNOT-22 questionnaire was evaluated by comparing the mean scores of 42 patients' quality of life after surgical treatment (Table 1) . A statistically significant improvement was observed between the mean preoperative SNOT-22 score (57.98±5.07) and postoperative mean score at 3 months (25.38±2.59) confirming a desirable level of responsiveness for the Turkish version of the questionnaire (p<0.001, Table 1 ).
Conclusion
In conclusion, we have showed that the Turkish version of SNOT-22 questionnaire is a valid outcome measuring tool for assessing quality of life of patients with CRS and the effectiveness of surgical treatment. The results indicated internal consistency, reliability, concurrent validity, and responsiveness to change. We believe that SNOT-22 questionnaire in Turkish, if regularly used by the clinicians, can obtain information about the full range of problems associated with CRS and the effectiveness of surgical treatment. 
